CVE-2014-3014
UnknownEPSS 1.40%
Last modified
CVE-2014-3014 is a vulnerability of currently unknown severity. Cross-site scripting (XSS) vulnerability in the Meeting Server in IBM Sametime 8.x through 8.5.2.1 and 9.x through 9.0.0.1 allows remote authenticated users to inject arbitrary web script or HTML via a crafted URL.. EPSS estimates a 1.40% chance of exploitation in the next 30 days.
Description
Cross-site scripting (XSS) vulnerability in the Meeting Server in IBM Sametime 8.x through 8.5.2.1 and 9.x through 9.0.0.1 allows remote authenticated users to inject arbitrary web script or HTML via a crafted URL.
Metrics
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Ibm | Sametime | 8.0.0.0 |
| Ibm | Sametime | 8.0.1.0 |
| Ibm | Sametime | 8.0.1.1 |
| Ibm | Sametime | 8.0.2.0 |
| Ibm | Sametime | 8.0.2.1 |
| Ibm | Sametime | 8.5.0.0 |
| Ibm | Sametime | 8.5.1.0 |
| Ibm | Sametime | 8.5.1.1 |
| Ibm | Sametime | 8.5.2.0 |
| Ibm | Sametime | 8.5.2.1 |
| Ibm | Sametime | 9.0.0.0 |
| Ibm | Sametime | 9.0.0.1 |
References
- http://www-01.ibm.com/support/docview.wss?uid=swg21671201Vendor Advisory
- http://www-01.ibm.com/support/docview.wss?uid=swg21671201Vendor Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2014-3014?
Cross-site scripting (XSS) vulnerability in the Meeting Server in IBM Sametime 8.x through 8.5.2.1 and 9.x through 9.0.0.1 allows remote authenticated users to inject arbitrary web script or HTML via a crafted URL.
How severe is CVE-2014-3014?
Severity scoring for CVE-2014-3014 is pending analysis. The EPSS model estimates a 1.40% probability of exploitation in the next 30 days.
How do I fix CVE-2014-3014?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2014-3014?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
